CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study von Cooper, C L, Davis, H L, Morris, M L, Efler, S M, Adhami, M Al, Krieg, A M, Cameron, D W, Heathcote, J

Volltext

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine von Cooper, C.L, Davis, H.L, Morris, M.L, Efler, S.M, Krieg, A.M, Li, Y, Laframboise, C, Al Adhami, M.J, Khaliq, Y, Seguin, I, Cameron, D.W

Volltext

Quantification of Oligodeoxynucleotides in Human Plasma with a Novel Hybridization Assay Offers Greatly Enhanced Sensitivity over Capillary Gel Electrophoresis von Efler, S.M., Zhang, L., Noll, B.O., Uhlmann, E., Davis, H.L.

Volltext